Literature DB >> 20734022

Guidelines: we'll always need them, we sometimes dislike them, and we have to make them better.

R Kahn1.   

Abstract

Mesh:

Year:  2010        PMID: 20734022     DOI: 10.1007/s00125-010-1885-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  34 in total

1.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

2.  Archimedes: a trial-validated model of diabetes.

Authors:  David M Eddy; Leonard Schlessinger
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

3.  Sources of bias for authors of clinical practice guidelines.

Authors:  Allan S Detsky
Journal:  CMAJ       Date:  2006-10-24       Impact factor: 8.262

4.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

5.  Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.

Authors:  David Eddy
Journal:  Health Aff (Millwood)       Date:  2007-06-19       Impact factor: 6.301

6.  Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.

Authors:  Robert J Smith; David M Nathan; Silva A Arslanian; Leif Groop; Robert A Rizza; Jerome I Rotter
Journal:  J Clin Endocrinol Metab       Date:  2010-03-01       Impact factor: 5.958

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

8.  Optimizing statin treatment for primary prevention of coronary artery disease.

Authors:  Rodney A Hayward; Harlan M Krumholz; Donna M Zulman; Justin W Timbie; Sandeep Vijan
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

9.  The interpretation of systematic reviews with meta-analyses: an objective or subjective process?

Authors:  Ian Shrier; Jean-François Boivin; Robert W Platt; Russell J Steele; James M Brophy; Franco Carnevale; Mark J Eisenberg; Andrea Furlan; Ritsuko Kakuma; Mary Ellen Macdonald; Louise Pilote; Michel Rossignol
Journal:  BMC Med Inform Decis Mak       Date:  2008-05-21       Impact factor: 2.796

10.  Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models.

Authors:  Michael Stern; Ken Williams; David Eddy; Richard Kahn
Journal:  Diabetes Care       Date:  2008-05-28       Impact factor: 19.112

View more
  3 in total

1.  Finnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatment.

Authors:  A Virkamäki; J Saltevo
Journal:  Diabetologia       Date:  2011-02-18       Impact factor: 10.122

Review 2.  Evidence base in guideline generation in diabetes.

Authors:  I Mühlhauser; G Meyer
Journal:  Diabetologia       Date:  2013-03-09       Impact factor: 10.122

3.  Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study.

Authors:  W David Strain; Abhijit S Agarwal; Päivi M Paldánius
Journal:  Aging (Albany NY)       Date:  2017-03-05       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.